Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
Q&A: Paving a New Path in Life After a Dementia Diagnosis, With Mark and Brenda Roberts
The Link Between Struggling to Hear Over Background Noise and Dementia Risk
What Games Should You Play For Better Brain Health?
Op-Ed: How COVID-19 Can Break Barriers Facing the Alzheimer’s Germ Theory
Cassava’s Simufilam Trial Data Still Under Scrutiny
Q&A: Insights From a Long-Running Study of Alzheimer’s Risk
What Kinds of Memories Are Lost in Alzheimer’s Disease?
Could Too Much Coffee Shrink Your Brain? (And Would It Matter?)
Review: These Devices Use Flashing Lights Designed to Boost Brain Health
Turning Hardship Into Hope in Dementia Caregiving
The Gut Microbiome in Aging and Cognitive Health
Some Alzheimer’s, Parkinson’s Therapies May Cause Brain Inflammation
Cassava Rebukes Fraud Allegations, Faces Calls to Halt Alzheimer’s Drug Phase III Trials
What Can We Learn From Amazonian Tribes’ Younger, Healthier Brains?
Renewed Interest for Galantamine, an 18-Year-Old Alzheimer’s Drug
Previous
78
79
80
Next
Page load link
Go to Top